Arsenic and human health: Epidemiologic progress and public health implications

Reviews on Environmental Health

Volumn 27, Issue 4, 2012, Pages 191-195

  Argos, Maria ^a   Ahsan, Habibul ^a   Graziano, Joseph H ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Mailman School of Public Health   (United States)

Author keywords

Arsenic; Asia; Drinking water; Human health

Indexed keywords

ARSENIC;

CONFERENCE PAPER; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; METABOLISM; NEWBORN; PREGNANCY; PUBLIC HEALTH;

ARSENIC; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL EXPOSURE; PREGNANCY; PUBLIC HEALTH;

EID: 84870950702     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/reveh-2012-0021     Document Type: Conference Paper

References (62)

1. Dhar R, Biswas B, Samanta G, Mandal B, Chakraborti D, et al. Groundwater arsenic calamity in Bangladesh. Curr Sci 1997;73:48-59. (Pubitemid 127441231)
2. McCarty KM, Hanh HT, Kim KW. Arsenic geochemistry and human health in South East Asia. Rev Environ Health 2011;26:71-8.
3. EPA. Arsenic and clarifications to compliance and new source monitoring rule: a quick reference guide, 2001. Available at: http://water.epa.gov/drink/ info/arsenic/upload/2005-11-10-arsenic- quickguide.pdf. Accessed 11 May, 2012.
4. BGS, DPHE. Arsenic contamination of groundwater in Bangladesh. Report No. BGS Technical Report WC/00/19, vol. 2. Keyworth: British Geological Survey, 2001.
5. Ng JC, Wang J, Shraim A. A global health problem caused by arsenic from natural sources. Chemosphere 2003;52:1353-9. (Pubitemid 41123337)
6. Smith AH, Lingas EO, Rahman M. Contamination of drinkingwater by arsenic in Bangladesh: a public health emergency. Bull World Health Organ 2000;78:1093-103.
7. International Agency for Research on Cancer (IARC). IARC Monograph on Arsenic and Arsenic Compounds. Lyon, France: IARC, 1987(Suppl 7):100.
8. Smith AH, Goycolea M, Haque R, Biggs ML. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am J Epidemiol 1998;147:660-9. (Pubitemid 28180309)
9. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 1992;66:888-92.
10. Hopenhayn-Rich C, Biggs ML, Fuchs A, Bergoglio R, Tello EE, et al. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1996;7:117-24. (Pubitemid 26068042)
11. Hopenhayn-Rich C, Biggs ML, Smith AH. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int J Epidemiol 1998;27:561-9. (Pubitemid 28431495)
12. Tseng WP. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 1977;19:109-19. (Pubitemid 8182684)
13. Brouwer OF, Onkenhout W, Edelbroek PM, de Kom JF, de Wolff FA, et al. Increased neurotoxicity of arsenic in methylenetetrahydrofolate reductase deficiency. Clin Neurol Neurosurg 1992;94:307-10. (Pubitemid 23015324)
14. Wu MM, Kuo TL, Hwang YH, Chen CJ. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 1989;130:1123-32.
15. Rahman M, Tondel M, Ahmad SA, Chowdhury IA, Faruquee MH, et al. Hypertension and arsenic exposure in Bangladesh. Hypertension 1999;33:74-8. (Pubitemid 29061844)
16. Heck JE, Chen Y, Grann VR, Slavkovich V, Parvez F, et al. Arsenic exposure and anemia in Bangladesh: a population-based study. J Occup Environ Med 2008;50:80-7.
17. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon, France: IARC, 2004;84.
18. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, et al. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am J Epidemiol 2005;162:1037-49. (Pubitemid 41746616)
19. States JC, Srivastava S, Chen Y, Barchowsky A. Arsenic and cardiovascular disease. Toxicol Sci 2009;107:312-23.
20. Tseng CH. Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. Atherosclerosis 2008;199:12-8.
21. Ahmad SA, Sayed MH, Barua S, Khan MH, Faruquee MH, et al. Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect 2001;109:629-31. (Pubitemid 32998776)
22. Milton AH, Smith W, Rahman B, Hasan Z, Kulsum U, et al. Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 2005;16:82-6. (Pubitemid 40239281)
23. von Ehrenstein OS, Guha Mazumder DN, Hira-Smith M, Ghosh N, Yuan Y, et al. Pregnancy outcomes, infant mortality, and arsenic in drinking water in West Bengal, India. Am J Epidemiol 2006;163:662-9.
24. Milton AH, Rahman M. Respiratory effects and arsenic contaminated well water in Bangladesh. Int J Environ Health Res 2002;12:175-9.
25. Parvez F, Chen Y, Brandt-Rauf PW, Bernard A, Dumont X, et al. Nonmalignant respiratory effects of chronic arsenic exposure from drinking water among never-smokers in Bangladesh. Environ Health Perspect 2008;116:190-5. (Pubitemid 351356725)
26. Rossman TG. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res 2003;533(1-2):37-65. (Pubitemid 37487860)
27. Tokar EJ, Benbrahim-Tallaa L, Ward JM, Lunn R, Sams RL 2nd, et al. Cancer in experimental animals exposed to arsenic and arsenic compounds. Crit Rev Toxicol 2010;40:912-27.
28. Andreae MO. Determination of arsenic species in natural waters. Anal Chem 1977;49:820-3.
29. Aposhian HV. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu Rev Pharmacol Toxicol 1997;37:397-419. (Pubitemid 27238882)
30. Le XC, Ma M, Cullen WR, Aposhian HV, Lu X, et al. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 2000;108:1015-8.
31. Del Razo LM, Styblo M, Cullen WR, Thomas DJ. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 2001;174:282-93. (Pubitemid 32747839)
32. Ahmad S, Anderson WL, Kitchin KT. Dimethylarsinic acid effects on DNA damage and oxidative stress related biochemical parameters in B6C3F1 mice. Cancer Lett 1999;139:129-35. (Pubitemid 29225111)
33. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect 2002;110(Suppl 5):767-71. (Pubitemid 35276864)
34. Hopenhayn-Rich C, Smith AH, Goeden HM. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res 1993;60:161-77. (Pubitemid 23121298)
35. Tseng CH. A review on environmental factors regulating arsenic methylation in humans. Toxicol Appl Pharmacol 2009;235:338-50.
36. Pierce BL, Kibriya MG, Tong L, Jasmine F, Argos M, et al. Genome-wide association study identifies chromosome 10q24.32 variants associated with arsenic metabolism and toxicity phenotypes in Bangladesh. PLoS Genet 2012;8:e1002522.
37. Hernandez A, Xamena N, Surralles J, Sekaran C, Tokunaga H, et al. Role of the Met(287)Thr polymorphism in the AS3MT gene on the metabolic arsenic profile. Mutat Res 2008;637(1-2):80-92. (Pubitemid 350256765)
38. Hernandez A, Marcos R. Genetic variations associated with interindividual sensitivity in the response to arsenic exposure. Pharmacogenomics 2008;9:1113-32.
39. Vahter M. Health effects of early life exposure to arsenic. Basic Clin Pharmacol Toxicol 2008;102:204-11. (Pubitemid 351143425)
40. Vahter M. Effects of arsenic on maternal and fetal health. Annu Rev Nutr 2009;29:381-99.
41. Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, et al. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev 2008;17:1982-7.
42. Lindberg AL, Rahman M, Persson LA, Vahter M. The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol Appl Pharmacol 2008;230:9-16.
43. Rahman M, Vahter M, Sohel N, Yunus M, Wahed MA, et al. Arsenic exposure and age and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Environ Health Perspect 2006;114:1847-52. (Pubitemid 44873684)
44. Fry RC, Navasumrit P, Valiathan C, Svensson JP, Hogan BJ, et al. Activation of infl ammation/NF-kappaB signaling in infants born to arsenic-exposed mothers. PLoS Genet 2007;3:e207.
45. Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, et al. Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol Biomarkers Prev 2006;15:1367-75. (Pubitemid 44125296)
46. Intarasunanont P, Navasumrit P, Woraprasit S, Chaisatra K, Suk WA, et al. Effects of arsenic exposure on DNA methylation in cord blood samples from newborn babies and in a human lymphoblast cell line. Environ Health 2012;11:31.
47. Van Geen A, Ahsan H, Horneman AH, Dhar RK, Zheng Y, et al. Promotion of well-switching to mitigate the current arsenic crisis in Bangladesh. Bull World Health Organ 2002;80:732-7.
48. Chen Y, van Geen A, Graziano JH, Pfaff A, Madajewicz M, et al. Reduction in urinary arsenic levels in response to arsenic mitigation efforts in Araihazar, Bangladesh. Environ Health Perspect 2007;115:917-23. (Pubitemid 46902247)
49. Madajewicz M, Pfaff A, van Geen A, Graziano J, Hussein I, et al. Can information alone change behaviořResponse to arsenic contamination of groundwater in Bangladesh. J Dev Econ 2007;84:731-54. (Pubitemid 47287374)
50. van Geen A, Ahmed KM, Seddique AA, Shamsudduha M. Community wells to mitigate the arsenic crisis in Bangladesh. Bull World Health Organ 2003;81:632-8. (Pubitemid 37254684)
51. George CM, Graziano JH, Mey JL, van Geen A. Impact on arsenic exposure of a growing proportion of untested wells in Bangladesh. Environ Health 2012;11:7.
52. Jain CK, Singh RD. Technological options for the removal of arsenic with special reference to South East Asia. J Environ Manage 2012;107C:1-18.
53. Kim KW, Chanpiwat P, Hanh HT, Phan K, Sthiannopkao S. Arsenic geochemistry of groundwater in Southeast Asia. Front Med 2011;5:420-33.
54. Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, et al. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 2010;376:252-8.
55. Chang CC, Ho SC, Tsai SS, Yang CY. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. J Toxicol Environ Health A 2004;67:1353-61.
56. Yang CY, Chiu HF, Chang CC, Ho SC, Wu TN. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan. Environ Res 2005;98:127-32.
57. Argos M, Kalra T, Pierce BL, Chen Y, Parvez F, et al. A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am J Epidemiol 2011;174:185-94.
58. Marshall G, Ferreccio C, Yuan Y, Bates MN, Steinmaus C, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 2007;99:920-8. (Pubitemid 47078729)
59. Fernandez MI, Lopez JF, Vivaldi B, Coz F. Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure. J Urol 2012;187:856-61.
60. Lokuge KM, Smith W, Caldwell B, Dear K, Milton AH. The effect of arsenic mitigation interventions on disease burden in Bangladesh. Environ Health Perspect 2004;112:1172-7. (Pubitemid 39157618)
61. Chen Y, Ahsan H. Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health 2004;94:741-4. (Pubitemid 38560375)
62. Adamson GC, Polya DA. Critical pathway analysis to determine key uncertainties in net impacts on disease burden in Bangladesh of arsenic mitigation involving the substitution of arsenic bearing for groundwater drinking water supplies. J Environ Sci Health A Tox Hazard Subst Environ Eng 2007;42:1909-17. (Pubitemid 47613777)